These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 3553617)
21. Medical treatment of impotence with papaverine and phentolamine intracavernosal injection. Dinsmore WW Ulster Med J; 1990 Oct; 59(2):174-6. PubMed ID: 2278115 [TBL] [Abstract][Full Text] [Related]
22. Penile self-injection for impotence in patients after radical cystectomy-ileal loop. Al-Juburi AZ; O'Donnell PD Urology; 1987 Jul; 30(1):29-30. PubMed ID: 3603906 [TBL] [Abstract][Full Text] [Related]
23. Impotence: treatment by autoinjection of vasoactive drugs. Williams G; Mulcahy MJ; Kiely EA Br Med J (Clin Res Ed); 1987 Sep; 295(6598):595-6. PubMed ID: 3117249 [TBL] [Abstract][Full Text] [Related]
24. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. Zorgniotti AW; Lefleur RS J Urol; 1985 Jan; 133(1):39-41. PubMed ID: 2578067 [TBL] [Abstract][Full Text] [Related]
25. [Priapism as a complication of the treatment of impotence by local injections of papaverine]. Kaczmarek A Wiad Lek; 1990 Sep 1-15; 43(17-18):908-10. PubMed ID: 2278150 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological treatment of erectile dysfunction after radical prostatectomy. Dennis RL; McDougal WS J Urol; 1988 Apr; 139(4):775-6. PubMed ID: 3352040 [TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. Lee LM; Stevenson RW; Szasz G J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589 [TBL] [Abstract][Full Text] [Related]
30. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. von Heyden B; Donatucci CF; Kaula N; Lue TF J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018 [TBL] [Abstract][Full Text] [Related]
31. Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. Gasser TC; Roach RM; Larsen EH; Madsen PO; Bruskewitz RC J Urol; 1987 Apr; 137(4):678-80. PubMed ID: 3550149 [TBL] [Abstract][Full Text] [Related]
32. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients. Fu Q; Yao DH; Jiang YQ Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421 [TBL] [Abstract][Full Text] [Related]
33. Development of fibrotic penile lesions secondary to the intracorporeal injection of vasoactive agents. Corriere JN; Fishman IJ; Benson GS; Carlton CE J Urol; 1988 Sep; 140(3):615-7. PubMed ID: 3411687 [TBL] [Abstract][Full Text] [Related]
34. [Intracavernous injection of vasoactive drugs for treating erectile impotence]. Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019 [TBL] [Abstract][Full Text] [Related]
35. [Diagnosis and treatment of impotence with administration of chemical prosthesis using real-time mechanical sector duplex scanner--with special reference to diabetic patients]. Nakajima Y; Shibayama T; Yamamoto H; Suzuki Y; Matsuoka K; Kaneda S Hinyokika Kiyo; 1989 Apr; 35(4):623-30. PubMed ID: 2472055 [TBL] [Abstract][Full Text] [Related]
36. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction. Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187 [TBL] [Abstract][Full Text] [Related]